We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

VEDA LAB

VEDALAB focuses on the development, production and marketing of in vitro immunodiagnostic reagents and instruments. I... read more Featured Products: More products

Download Mobile App




Specificity of Rheumatoid Factor Detected by Latex Fixation Compared

By LabMedica International staff writers
Posted on 02 Sep 2020
Print article
Image: The RF direct latex tests for the detection of rheumatoid factor (RF) in serum (Photo courtesy of VedaLab).
Image: The RF direct latex tests for the detection of rheumatoid factor (RF) in serum (Photo courtesy of VedaLab).
Rheumatoid arthritis is a chronic inflammatory and autoimmune disorder that can affect more than just the joints. In some people, the condition can damage a wide variety of body systems, including the skin, eyes, lungs, heart and blood vessels.

Rheumatoid factor (RF), originally defined as pathological autoantibodies to immunoglobulin G (IgG) that are detected in rheumatoid arthritis, but has turned out to be multi‐specific antibodies, some of which exhibit immunoregulatory properties. The functions of rheumatoid factor and its role in the development of autoimmune disease remain a mystery.

Immunologists at the Udmurt State University (Izhevsk, Russia) obtained sera from patients with rheumatoid arthritis or symptoms of joint pain and swelling. IgG that was considered native was isolated from the blood plasma of healthy donors by precipitation with ammonium sulfate and purified by size‐exclusion chromatography. The native IgG was used in a competitive assay.

The RF direct latex test (VedaLab, Cerisé, France) was used to detect rheumatoid factor in the patients’ sera. The agglutination activity of the sera was scored from “+++” (or 3) to “−” (or 0). In some samples, the titer was determined. Regulatory rheumatoid factor (regRF) titer was determined in an agglutination test using human IgG‐loaded tanned human erythrocytes. To produce papain Fc fragments of IgG, the team used the limited proteolysis method. Human IgG (Equitech‐Bio, Kerrville, TX, USA) was digested by papain and processed. The RF titer in rheumatoid arthritis serum was determined by latex fixation.

The investigators reported that regRF and pathology‐associated RF constitute different antibody populations. Pathology‐associated RF is specific for lyophilized IgG. RegRF does not interact with IgG. RegRF is specific to conformers of IgG Fc fragments that have a reduced hinge. In latex‐positive rheumatoid arthritis sera, regRF may be present in addition to pathology‐associated RF. The latex fixation method detects both rheumatoid factor populations.

The authors concluded that RegRF and pathology‐associated RF are populations of rheumatoid factor that have different specificity. RegRF is specific for conformers IgG Fc fragments that have a reduced hinge, but not for IgG. Pathology‐associated RF is specific for epitopes appearing on lyophilized IgG. In latex‐positive rheumatoid arthritis sera, regulatory rheumatoid factor may be present in addition to pathology‐associated RF. The latex fixation method detects both rheumatoid factor populations. The tanned IgG‐loaded erythrocyte agglutination test selectively detects regulatory rheumatoid factor. The study was published on August 12, 2020 in the Journal of Clinical Laboratory Analysis.




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.